Clinical Trials Using Risedronate Sodium

Clinical trials are research studies that involve people. The clinical trials on this list are studying Risedronate Sodium. All trials on the list are supported by NCI.

NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.

Trial 1 of 1
  • Prophylactic Risedronate in Reducing Rapid Bone Loss in Patients with Peripheral Lung Tumors Who Are Undergoing SBRT

    This phase II trial studies how well prophylactic risedronate works in reducing rapid bone loss in patients with peripheral lung tumors who are undergoing stereotactic body radiation therapy (SBRT). Risedronate is a type of drug called a bisphosphonate. This type of medicine is commonly used to decrease bone loss in people who have osteoporosis, but it has not been given to stop bone loss that is caused by radiation. Giving risedronate prior to SBRT may stop or decrease bone loss that is caused by radiation. This could potentially lead to fewer rib or backbone fractures and could mean patients experience less chest or back pain after radiation.
    Location: 2 locations